web analytics

Rotmans, RxAir, The Rise of Vystar Corp. (OTC: VYST)

0

Vystar Corp. (OTC: VYST) is an exciting story in small caps that is starting to get noticed by investors. The stock is heating up in recent trading since a brief dip below the $0.03 mark. VYST has been on the OTC for years and has runner in its blood with a long history of big moves making a specular run in early 2019 from triple zeroes to over $0.15 highs. The recent run up reached $0.10 at the beginning of August and speculators are accumulating at current levels looking for a return to these levels.

VYST has turned into a revenue powerhouse with Rotmans furniture under its umbrella. The Company recently reported $8,321,144 in sales for the 6 months ended June 30, 2020 on track to beat its 2019 numbers, when Vystar reported $13,685,872 in revenues. Its newest division; RxAir promotes a healthy lifestyle through the use of its innovative, patented ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by EPA- and FDA-certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and Volatile Organic Compounds (“VOCs”).

Vystar Corp. (OTC: VYST) is based in Worcester, Massachusetts. The Company uses patented technology to produce a line of innovative air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. In addition, Vystar manufactures and sells reduced allergen natural rubber latex used primarily in various bedding products. Vystar has a majority ownership in Murida Furniture Co., Inc. dba Rotmans Furniture, the largest furniture and flooring store in New England and one of the largest independent furniture stores in the U.S.

Vystar is the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. Vytex is currently used in multiple mattress lines, including Symbol™ and Gold Bond®; Jeffco manufactured components for toppers and mattresses, which are sold to multiple manufacturers; and private label toppers, pillows and mattresses sold online via Amazon. Vytex is also used in industrial adhesives, apparel padding and threads, shoes, sports equipment and electrical gloves and Vytex 3D printed fabrics available through partners like Tami Care. Liquid Vytex can be ordered wholesale through Halcyon Agri’s RCMA and CentroTrade.

RXAIR UV Air Purifier - The Trusted Choice of HospitalsVystar subsidiary RxAir promotes a healthy lifestyle through the use of its innovative, patented ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by EPA- and FDA-certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and Volatile Organic Compounds (“VOCs”). The RxAir uses high-intensity germicidal UV lamps that destroy bacteria and viruses instead of just trapping them, setting it apart from ordinary air filtration units. RxAir® and ViraTech ® are registered trademarks of UV Flu Technologies, Inc. RxAir product lines includes RXair™ Residential Filterless Air Purifier. UV400 ™ FDA cleared Class II Filterless Air Purifier. RX3000™ Commercial FDA cleared Class II Air Purifier (news video with RX3000). In 2019, Vystar acquired all UV Flu intellectual property, multiple patents, product lines, tooling, FDA clearances, research data, websites and other assets related to the business. VYST recently reported its Rx3000 is used in hundreds of hospitals and healthcare facilities.

To Find out the inside Scoop on VYST Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

VYST

RxAir is a powerful filterless UV-C Light Air Purifier that destroys more than 99% of airborne bacteria and viruses, including the flu, H1N1, multiple Coronavirus strains, pneumonia, MRSA, strep, TB, measles and the common cold*. RxAir kills bacteria that can make it difficult to sleep, and reduces risk for those who suffer from respiratory conditions or a weakened immune system. Use RxAir to effectively neutralize odors, indoor pollutants, and VOCs (volatile organic compounds) *Independent laboratory testing and research by Dr. Wladyslaw Kowalski, one of the world’s foremost authorities on hospital airborne infection control, confirms that the RxAir destroys these and many other antibiotic-resistant bacteria and viruses. Used RXAIR 3000 Portable Air Purifier For Sale - DOTmed Listing #798959:RxAir® UV-C Light Air Purifier System Fights bacteria and viruses so you don’t have to and is an FDA Certified Class ll Medical Device. The RxAir® is the best way to protect your family, staff and customers from airborne viruses & bacteria such as multiple coronavirus and influenza strains, staph, pneumonia & strep. The product is Proven effective in testing at independent FDA and EPA certified labs. It Delivers the correct wavelength and duration of ultraviolet-C light for inactivating >99.9% of viruses, bacteria and fungi. Reduces the risk of infection by inactivating/killing rather than trapping live pathogens.

Designed by biomedical engineers, Rx3000 combines patented ViraTech™ germicidal UV-C light with a patented five-stage HEPA filtration to provide UV-C germicidal irradiation (UVGI). Rx3000 has been proven in independent EPA- and FDA-certified laboratory testing to inactivate on first pass more than 99.97% of airborne viruses, bacteria and other contaminants, including those that cause pneumonia, influenza, MRSA (staph), streptococcus (whooping cough), tuberculosis (TB), measles and a myriad of other antibiotic-resistant and viral infections. 6, 7, 8. reported in August that it has engaged Strategic Link Assoc. to manage the supply chain, logistics and manufacturing of Vystar’s Rx3000®,

Recently Vystar reported Rotmans Furniture and Flooring is coming back strong from the covid shutdown. Approximately 60% of employees have been re-hired, and offers for re-employment have been extended to many others. However, some employees are opting not to return due to risk of COVID-19 exposure. The Company has adapted to the new “COVID normal” by extending sales over weeks to prevent large crowds and maintain social distancing. Sales have been strong; CEO Steve Rotman stated: “On the bright side, immediately after we reopened Rotmans in June, we experienced a surge of pent up buying among customers who had delayed purchases since March. Typically, 30 to 40 percent of customers make purchases, but instead 50-70 percent were making purchases. That has since tapered off somewhat, but we are still tracking higher than normal for year over year sales for the months of June and July and we are doing it with fewer employees than normal.”

We have a Monster Pick Coming. Subscribe Right Now!

Vystar is an exciting Company in small caps that is on the move upwards again. VYST has turned into a revenue powerhouse with Rotmans furniture under its umbrella. Vystar recently reported $8,321,144 in sales for the 6 months ended June 30, 2020 on track to beat its 2019 numbers, when Vystar reported $13,685,872 in revenues. VYST has 1,118,718,315 shares out as of September 18 with Authorized capped at 1.5b. VYstar newest division; RxAir promotes a healthy lifestyle through the use of its innovative, patented ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by EPA- and FDA-certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and Volatile Organic Compounds (“VOCs”). Vystar Rx3000 combines patented ViraTech™ germicidal UV-C light with a patented five-stage HEPA filtration to provide UV-C germicidal irradiation (UVGI). is already being used in hundreds of hospitals and healthcare facilities. Microcapdaily first reported on VYST on January 4, 2019 when the stock was $0.0005. We will be updating on VYST when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with VYST.

Sign Up now for our 100% FREE Penny Stock Newsletter

Disclosure: we hold no position in VYST either long or short and we have not been compensated for this article.

Share.

Leave A Reply

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.